BioCentury | Mar 1, 2019
Company News

Clementia takeout to bolster Ipsen’s orphan pipeline

...Nutropin AQ for growth failure, Increlex mecasermin for growth delay and cancer therapy Decapeptyl triptorelin pamoate...
BioCentury | Feb 25, 2019
Company News

Clementia takeout to bolster Ipsen’s orphan pipeline

...Nutropin AQ for growth failure, Increlex mecasermin for growth delay and cancer therapy Decapeptyl triptorelin pamoate...
BioCentury | May 23, 2018
Distillery Techniques

Disease models

...and fertility defects observed in PCOS patients. In the model mice, the GnRH/LHRH antagonist Cetrotide cetrorelix...
...screen other PCOS therapies. Aeterna Zentaris Inc., Merck KGaA and Nippon Kayaku Co. Ltd. market Cetrotide...
...de la Santé et de la Recherche Médicale (INSERM), Lille, France email: paolo.giacobini@inserm.fr Hongjiang Li Cetrotide, cetrorelix (pamoate) Institut...
BioCentury | Aug 31, 2017
Translation in Brief

Gene, score, match

...proliferation of five cultured HCC cell lines. The team tested the most potent compound, pyrvinium pamoate...
...mouse xenograft model of HCC and found it decreased tumor volume compared with vehicle. Pyrvinium pamoate...
BioCentury | Jul 27, 2017
Clinical News

FDA approves Triptodur for central precocious puberty

...Atlanta, Ga. Debiopharm Group , Lausanne, Switzerland Product: Triptodur triptorelin Business: Endocrine/Metabolic Julian Zhu Debio 8206 SC Decapeptyl Triptorelin triptorelin pamoate Arbor...
BioCentury | Mar 31, 2017
Targets & Mechanisms

Cells on the rise

...cancer has only three: the VEGF inhibitor Avastin bevacizumab; the GnRH/LHRH receptor agonist Decapeptyl triptorelin pamoate...
BioCentury | Mar 22, 2017
Clinical News

Decapeptyl regulatory update

...U.K.’s Medicines and Healthcare products Regulatory Agency (MHRA) approved a label expansion for Decapeptyl triptorelin pamoate...
...recurrence or who are confirmed premenopausal after completion of chemotherapy. The controlled-release formulation of triptorelin pamoate...
...Euronext:IPN; Pink:IPSEY), Boulogne-Billancourt, France Product: Decapeptyl triptorelin pamoate (Trelstar) (Debio 8206) Business: Cancer Julian Zhu Debio 8206 Decapeptyl Trelstar triptorelin pamoate Ipsen...
BioCentury | Nov 16, 2015
Company News

Primm Pharma, Xbrane deal

...approval in Italy. Xbrane said the product, which is a slow-release formulation of Decapeptyl triptorelin pamoate...
BioCentury | Jul 20, 2015
Clinical News

Triptorelin pamoate: Phase III data

...with CPP showed that 2 intramuscular injections of a 6-month formulation of 22.5 mg triptorelin pamoate...
...puberty were stable or reduced in 89% of patients between baseline and month 12. Triptorelin pamoate...
...countries for various indications, including advanced prostate cancer and CPP. Actavis has rights to triptorelin pamoate...
BioCentury | Jan 22, 2015
Targets & Mechanisms

Pseudo-allergy exposed

...of all the cationic drug classes associated with injection site reactions, including Firazyr icatibant, Cetrotide cetrorelix...
...MRGPRX2-deficient mice. Firazyr is a bradykinin B2 receptor agonist marketed by Sanofi to treat angioedema. Cetrotide...
Items per page:
1 - 10 of 122